INTRODUCTION
VLBW and LBW neonates are defined as a birth weight less than 1,500 g and 2,500 g, respectively [1] . These neonates obviously contribute to neonatal morbidity and mortality [2] . As reported, these neonates also have more developmental difficulties in later life, such as behavioral and emotional problems, cardiovascular disease and metabolic disease [3, 4] . The most important and direct developmental factors in the newborns are their nutritional and metabolic profiles, which can be reflected by AA and AC [5] . AA is a source of protein synthesis and supply to the tissues which plays a pivotal role in maintaining organ and body protein homeostasis [6, 7] . AC profile is a powerful tool for neonatal screening and diagnosis of fatty acid oxidation and organic acid disorders [8, 9] . AA and AC can play an essential role in the organism's metabolism. Shijiazhuang maternity hospital included newborn screening in January 2015. Up to now, nearly 50 thousand newborns have been screened. A variety of congenital genetic metabolic diseases have been discovered in early stages. It ensured that the newborns with congenital genetic metabolic diseases could be treated in the early stages of the disease. LC/MS/MS is an excellent tool to quantify AA and AC in dried blood spots (DBS) and is widely applied to routine newborn screening [10] . However, there are limited data about AA and AC profiles of LBW and VLBW neonates. Whether the concentrations of AA and AC in these neonates can offer some information about neonatal metabolic or nutritional status is still unknown. As reported previously, AA and AC concentrations varied obviously with birth weight [11] ; therefore, VLBW and LBW neonates may have different mean values from NW neonates, and different cutoffs need to be defined to reduce the risks of false-positive cases [12] . Thus, the aim of the present study was to identify the AA and AC profiles in DBS specimens of LBW and VLBW neonates, then compare with NW neonates, and make a contribution to the determination of cutoff values of VLBW and LBW neonates.
MATERIALS AND METHODS

Study subjects
A total of 252 newborns were selected from regular screening at Shijiazhuang maternity hospital from May to November 2017. Table 1 shows the essential information of the newborns in each group. Exclusion criteria include refusal of parental consent, evidence of a major congenital anomaly, and maternal complication during pregnancy, such as preeclampsia, diabetes mellitus, cholestasis syndrome, oligohydramnios, and polyhydramnios.
Sample collection and pretreatment DBS specimens were obtained from each neonate at 72 hours of life. Whole blood was drawn by heel prick and spotted on filter paper. The paper was dried at room temperature prior to starting pretreatment. For sample treatment methods please refer to the references [12] . A single 3-mm diameter DBS was placed in a well of a 96-well microtiter polystyrene plate, followed by addition of 90 µL extraction solution based on the deuterium-labeled internal standards (Yingsheng, China; amino acids: acyl carnitine: extraction solution = 1/1/198). The micro well plate was covered with viscous plastic sealing film and incubated for 45 minutes at 30°C with shaking at 650 rpm in a shaker (Thermo Fisher Scientific, USA). After seal removal, aliquots of the sample extracts (70 µL) were transferred to heat resistant 96-well microplate (Yingsheng, China), then covered with aluminum foil; it was then ready for HPLC-MS analysis. The remaining samples were stored at -80°C for subsequent analysis.
LC/MS/MS detection
Concentrations of 11 AA and 30 AC from DBS specimens were analyzed by flow injection using liquid chromatography LC-20AD (Shimadzu, Japan) coupled with API 3200 triple-quadrupole tandem mass spectrometer (AB Sciex, USA). The LC-MS/MS system also includes a Prominence LC-20AD series auto sampler and an AB Sciex series liquid chromatography pump that were employed to transfer 20 µL of each sample directly into the ion spray probe. AC and AA were analyzed in the multiple reaction monitoring (MRM) modes by the directions for the use of tandem mass spectrometry kit for AA and AC (Yingsheng, China). The method is described by George MP et al. [13] . Concentrations of AC and AA were measured by integrating the peak areas and fitting with calibration curves by using Analyst 1.6.2 software (AB Sciex, USA). Before analyzing the DBS samples, the analytical performance of LC-MS/ MS was verified.
Statistics
Statistical analysis was performed with SPSS 13.0 software. Measurement data were expressed by X ± SD. Most data followed a normal distribution except Ala, C4, and C16. A t-test was used to determine statistically significant differences between groups (p < 0.05). Rank-sum test was used for the comparison of the group Ala, C4, and C16.
RESULTS
Analytical Performance of the LC/MS/MS method Linear range verification
In this study, the linear ranges of 11 AA and 13 AC were investigated. High concentration specimens were selected and diluted into five different gradients. According to the proposed pretreatment and detection methods, each concentration was tested 3 times, and then the mean concentration of each dilution was calculated. The diluted concentration x was determined as the independent variable and the measured concentration y as the dependent variable, the linear equation y = ax + b and the correlation coefficient R were obtained. The results are shown in Table 2 .
Reproducibility and imprecision
The high-and low-quality control DBS in the kit were detected 12 times in one day, the minimum and maximum values of the 12 measurements were removed, and the average (M), standard deviation (SD), coefficient of variation (CV) of the 10 measurements were calculated; then they were compared with the target values which were provided by the manufacturer and the bias calculated. The results are shown in Table 3 and Table 4 . In the low-quality control DBS, the maximum detection CV and bias for each analysis was 8.0% and 10.2%, respectively; in the high-quality control DBS, the maximum detection CV and bias for each analysis was 9.2% and 11.5%, respectively, indicating a satisfactory imprecision of the method.
AA and Acylcarnitine Profiles in DBS
The AA concentrations in DBS of VLBW, LBW, and NW neonates are shown in Table 5 ; p-values between different groups were calculated. Data were expressed as medians ± SD. p < 0.05 was required for statistical significance. Compared with NW group, all the amino acids except Arg were significantly lower in the VLBW group, and the difference was statistically significant. The concentrations of amino acids, except Arg and Cit, were significantly lower in the LBW group than in the NW group, while levels of Cit were statistically higher in the LBW group than in the VLBW group. The AC concentrations of the neonate subgroups are shown in Table 6 . p-values between different groups were calculated. The concentrations of C0, C5, C5:1, C18:2 were significantly higher in VLBW than those in NW, while the levels of such 23 AC (C2, C3, C4OH + C3DC, C5DC + C6OH, C6, C6DC, C8:1, C10, C10:1, C10:2, C12, C12:1, C14, C14:1, C14:2, C14OH, C16, C16:1, C16:1OH, C18, C18:1, C18:1OH, C18OH) were statistically lower in VLBW than those in NW. The levels of C4 and C8 had no obvious differences between VLBW and NW. Most ACs in LBW and NW groups were significantly different (p < 0.05), except 7 AC (C2, C3, C5OH + C4DC, C5DC + C6OH, C10, C14, C18:1OH). The levels of C4OH + C3DC, C10:1, C12, C12:1, C14:1, C14OH, C16, C16:1, C16:1OH, C16OH, C18, C18:1, C18OH were statistically lower in LBW than those in NW, and other ACs were statistically higher in LBW group. Most ACs in VLBW and LBW groups were significantly different (p < 0.05), except 4 ACs (C0, C4, C5OH + C4DC, C5:1, C18). The level of C18:2 was statistically higher in VLBW than that in LBW, and other ACs were statistically lower in VLBW group. As reported Liu Q et al. [12] , the concentrations of most AA and AC were lower in LBW group, compared to those in NW neonates. In this study, the concentrations of Tyr, Leu, Val, and Pro were statistically lower in the LBW group, which basically is consistent with that study. Liu Q et al. [12] also reported that the levels of such measurements as C0, C3, C4 and C18:2 were statistically higher in the LBW group than those in the NW group, which also is consistent with this study.
DISCUSSION
It is well known that AC and AA profiling are used for the biochemical screening of amino acids, fatty acid oxidation, and organic acid metabolic disorders, which may help to diagnosis many metabolic defects, such as phenylketonuria, methylmalonic acidemia, and hereditary tyrosinemia [14, 15] . However, there are limited data about AA and AC profiles of LBW and VLBW neonates. Whether the concentrations of AA and AC in these neonates can offer some information about neonatal metabolic or nutritional status is still unknown. The LC/MS/MS method is an excellent tool to quantitatively detect AA and AC profiles [16, 17] . In this study, the performance (precision, accuracy, and linearity) of the LC/MS/MS method was verified, and it was found that the LC/MS/MS method showed a wide linear range and satisfied precision and reproducibility in detecting AA and AC of DBS specimens. The method was used to analyze AA and AC profiles in DBS of VLBW, LBW, and NW neonates, and compared the difference of AA and AC in the three groups. According to research, most AA and AC concentrations in the LBW and VLBW groups were significantly lower than those in the NW group. The results also showed that Arg concentration in the LBW and VLBW groups was significantly higher than in the NW group. Arg participates in the urea cycle and decreases when the body is immature or under severe stress [18] . Some studies have suggested that Arg supplementation is beneficial to neonatal growth and development [19] ; however, others have suggested that Arg supplementation does not show useful results [20] . The results of this study showed that the Arg concentration in the blood of LBW and VLBW neonates was significantly higher than that in NW neonates, suggesting that the significance of supplementation of Arg in LBW and VLBW neonates should be further confirmed. The levels of the measurements of C0, C5, C5:1 and C18:2 were statistically higher in LBW and VLBW groups. AC is a conditional essential nutrient in neonates due to the incomplete development of endogenous acylcarnitine synthesis mechanism, which can occur in liver and kidney from lysine and methionine when needed in adults [21] .
There are significant differences in most AA and AC concentrations in the blood of LBW, VLBW, and NW neonates. The application of LC/MS/MS in screening congenital metabolic defect diseases needs to establish different reference ranges.
CONCLUSION
The data in this study can be used as a reference to LC/ MS/MS in detecting AA and AC in LBW and VLBW neonates. This study played an essential role in diagnosing and screening of AA and AC metabolism disease, and it is significant to reduce the risk of false-positive cases in the screening.
